EDESA - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 and SOC versus Placebo and SOC in Adult Hospitalized Patients with COVID-19
The purpose of this study is to evaluate the clinical efficacy and safety of EB05 and Standard of Care vs. Standard of Care alone in adult hospitalized patients with COVID-19. This is a Phase II/III study conducted in two stages: Stage 1 (Phase II) and Stage 2 (Phase III). Furthermore, some patients will be part of the Main Study and others will be part of the sub-study depending on their initial disease severity.
This study is currently enrolling.